Related to Access Genetics to Offer Caliper’s LabChip GX as Molecular Diagnostic

• Empire Genomics Nabs Prostate Cancer Biomarker from Cornell
  
• Lumora Cuts Veterinary MDx Deal
  
• GSK Hits Trifecta with Melanoma Drug, Dx Approvals
  
• Biomarker Study Suggests Potential Alternative to Colonoscopy
  
• Study: Genetic Testing Uptake within Cancer-Affected Families Remains Low
  
• Techne Buys Bionostics for $104M
  
• Caliper Partners with Prestwick Chemical to Offer Services for Drug Discovery
  
• Caliper’s microCT Imaging Device to Be Used in NCI’s Preclinical Lung Cancer Studies
  
• Agilent to Use Caliper Microfluidic Chips for Seven More Years
  
• Caliper Life Sciences and Sony DADC to Develop Plastic Microfluidic Solutions
  
• NuGEN and Caliper Couple Solutions to Automate NGS Sample Prep
  
• IntegenX Licenses Caliper Microfluidics for Use in DNA Profiling Identification System
  
• Caliper and Covaris Ally to Simplify Sample Prep for Next-Generation Sequencing
  
• Caliper and HistoRx Combine Platforms to Develop Tissue Protein Analysis System
  
• Caliper Partners with Catholic Health Initiatives to Augment Methods for Testing Anticancer Candidates
  
• Roche and Caliper to Offer Automated Target Enrichment for Next-Generation Sequencing
  
• Genomics Departments at Yale and Erasmus Universities Adopt Caliper's Sciclone NGS Workstation
  
• Caliper to Accommodate DxTerity’s NEAT Multiplex Assays on LabChip Dx Platform
  
• Illumina to Co-Market Caliper Technologies to Improve Sequencing Workflows
  
• Seegene’s SeePlex Multiplex MDx Assays Available for Caliper’s LabChip Dx Platform